Vor announced it entered into a securities purchase agreement for a private investment in public equity financing. The ...

Vor Bio (NASDAQ:VOR) shares soared more than 20% in Friday pre-market trading, after it said that it has entered into a ...

A Buddha Air flight made a VOR landing at Tribhuvan International Airport in Nepal's Kathmandu on Monday after sustaining a ...

Vor Bio (VOR) announced the appointment of Erez Kalir to its Board of Directors. The appointment represents a new seat on Vor Bio’s Board of ...

Dec. 09, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, to Company to present trem-cel + Mylotarg clinical data update at American Society of ...

Wedbush has recently initiated Vor Biopharma Inc (VOR) stock to Outperform rating, as announced on July 26, 2022, according to Finviz. Earlier, on April 27, 2022, Goldman had initiated the stock to ...

Vor Biopharma Inc (VOR) stock saw a modest uptick, ending the day at $1.27 which represents a slight increase of $0.43 or 51.19% from the prior close of $0.84. The stock opened at $0.99 and touched a ...

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase ...

A Buddha Air flight made a VOR-assisted emergency landing at Tribhuvan International Airport (TIA) today after experiencing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of ...